Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2005-11-15
2005-11-15
Badio, Barbara P. (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S182000
Reexamination Certificate
active
06964954
ABSTRACT:
Methods of improving the appearance of keratinous substances using at least one DHEA derivative such as the skin, hair, eyelashes and/or nails, in particular for preventing or treating cutaneous signs of ageing and/or a faded complexion and/or disorders of pigmentation of the skin or hair and/or drying of the skin and/or hyperseborrhoea and/or imperfections relating to hyperseborrhoea and/or sensitive skin and/or dandruff and/or hair loss and/or canities.
REFERENCES:
patent: 5714481 (1998-02-01), Schwartz et al.
patent: 5843932 (1998-12-01), Labrie
patent: 6399084 (2002-06-01), Zenk et al.
patent: 2003/0054021 (2003-03-01), Dalko et al.
patent: 1 145 705 (2001-10-01), None
patent: WO 98/40074 (1998-09-01), None
patent: WO 00/28996 (2000-05-01), None
patent: WO 01/23405 (2001-04-01), None
patent: WO 03/035023 (2003-05-01), None
Ergosteroids II: Biologically active metabolites and synthetic derivatives of dehydroepiandrosterone,Steroids, 1998, vol. 63, Mar.
Cavezza Alexandre
Dalko Maria
"L'Oreal"
Badio Barbara P.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
LandOfFree
Use of DHEA derivatives on keratinous substances does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of DHEA derivatives on keratinous substances, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of DHEA derivatives on keratinous substances will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3513928